Disorders | DALYs (95% CI) | Death (95% CI) | Incidence (95% CI) | Prevalence (95% CI) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Count | ASDR (per 100,000 population) | AAPC for ASDR (%) | P-value | Count | ASMR (per 100,000 population) | AAPC for ASMR (%) | P-value | Count | ASIR (per 100,000 population) | AAPC for ASIR (%) | P-value | Count | ASPR (per 100,000 population) | AAPC for ASPR (%) | P-value | |
HIV/AIDS | 16,378,796.14 (13,002,587.28–20,997,995.28) | 829.75 (658.24–1063.9) | 1.6 (1.14 to 2.07) |  < 0.001 | 265,696.44 (205,247.78–348,436.39) | 13.39 (10.34–17.56) | 1.58 (1.09 to 2.06) |  < 0.001 | 670,804.13 (579,764.81–782,486.58) | 34.73 (30.03–40.54) | − 1.93 (− 2.22 to − 1.65) |  < 0.001 | 16,497,874.15 (15,584,846.64–17,544,995) | 830.87 (784.57–884.29) | 3.85 (3.48 to 4.22) |  < 0.001 |
Sexually transmitted infections excluding HIV | 700,302.55 (416,101.03–1170891.54) | 35.45 (21.1–59.17) | − 0.15 (− 0.18 to − 0.11) |  < 0.001 | 2215.02 (1345.93–3147.82) | 0.11 (0.07–0.16) | − 1.28 (− 1.48 to − 1.08) |  < 0.001 | 286,514,651.39 (203,966,590.72–390,280,447.3) | 14,579.13 (10,398.78–19,805.4) | 0.13 (0.05 to 0.21) | 0.002 | 544,454,239.16 (462,796,611.55–636,018,560.96) | 27,477.76 (23,342.43–32,118.6) | 0.12 (0.08 to 0.16) |  < 0.001 |
Premenstrual syndrome | 7,427,207.92 (4,148,170.82–12,131,572.89) | 379.98 (212.13–621.53) | 0.04 (0.03 to 0.05) |  < 0.001 | NA | NA | NA | NA | 232,596,759.97 (143,119,886.08–330272130.4) | 11,993.65 (7373.61–17,033.12) | 0.04 (0.03 to 0.06) |  < 0.001 | 889,970,473.02 (618,097,378.23–1,185,904,888.28) | 45,504.28 (31,591.54–60,679.05) | 0.04 (0.03 to 0.05) |  < 0.001 |
Endometriosis | 1,939,179.55 (1,043,871.12–3,250,764.22) | 98.69 (53.12–165.44) | − 0.98 (− 1.03 to − 0.94) |  < 0.001 | 46.72 (16.87–106.87) | 0 (0–0.01) | 0.8 (0.31 to 1.29) | 0.001 | 3,439,457.24 (1,795,773.54–5,603,240.06) | 178.52 (93.66–290.2) | − 0.97 (− 1 to − 0.93) |  < 0.001 | 21,045,890.51 (12,874,335.18–31,892,235.3) | 1070.7 (654.43–1623.79) | − 0.98 (− 1.03 to − 0.94) |  < 0.001 |
Female infertility | 601,133.5 (124,293.13–1,716,290.98) | 30.55 (6.32–87.18) | 0.68 (0.58 to 0.78) |  < 0.001 | NA | NA | NA | NA | NA | NA | NA | NA | 110,089,459.27 (31,051,019.4–254,716,760.03) | 5586.19 (1580.25–12,917.2) | 0.66 (0.57 to 0.76) |  < 0.001 |
Polycystic ovarian syndrome | 576,045.19 (255,576.76–1,200,184.51) | 29.51 (13.09–61.49) | 0.79 (0.75 to 0.84) |  < 0.001 | NA | NA | NA | NA | 1,175,074.43 (711,336.35–1,887,245.89) | 64.44 (39.07–103.4) | 0.7 (0.67 to 0.72) |  < 0.001 | 65,767,552.9 (46,839,857.45–91,498,217.36) | 3364.53 (2395.08–4681.81) | 0.81 (0.77 to 0.85) |  < 0.001 |
Uterine fibroids | 99,024.6 (66,843.42–141,126.74) | 4.92 (3.32–7.02) | 0.01 (− 0.15 to 0.16) | 0.948 | 996.98 (586.28–1318.93) | 0.05 (0.03–0.07) | − 0.28 (− 0.43 to − 0.13) |  < 0.001 | 9,830,184.7 (4,977,545.72–16,246,619.07) | 494.22 (249.78–817.56) | 0.25 (0.21 to 0.28) |  < 0.001 | 85,180,728.48 (56,514,987.95–122,225,847.11) | 4221.75 (2797.57–6064.56) | 0.17 (0.14 to 0.21) |  < 0.001 |
Genital prolapse | 101,961.39 (46,950.67–209,482.13) | 5.01 (2.3–10.3) | − 0.77 (− 0.81 to − 0.73) |  < 0.001 | 20.74 (12.45–29.5) | 0 (0–0) | − 1.13 (− 1.34 to − 0.93) |  < 0.001 | 5,629,892.91 (3,416,878.3–8,480,665.02) | 277.83 (168.76–418.44) | − 0.64 (− 0.67 to − 0.62) |  < 0.001 | 32,019,655.76 (21,885,504.05–44438602.12) | 1571.79 (1073.15–2184.28) | − 0.78 (− 0.81 to − 0.74) |  < 0.001 |
Cervical cancer | 4,184,314.17 (3,751,959.2–4,659,907.95) | 206.68 (185.28–230.25) | − 1.2 (− 1.33 to − 1.08) |  < 0.001 | 81,639.89 (73,425.84–90,920.78) | 4.02 (3.61–4.47) | − 1.26 (− 1.38 to − 1.13) |  < 0.001 | 307,427.99 (278,346.99–338,666.85) | 15.21 (13.77–16.76) | − 0.4 (− 0.49 to − 0.31) |  < 0.001 | 2,046,773 (1,858,237.66–2,254,921.98) | 101.49 (92.14–111.81) | − 0.01 (− 0.11 to 0.09) | 0.855 |
Uterine cancer | 373,681.68 (308,480.56–426,329) | 18.29 (15.09–20.88) | − 1.02 (− 1.23 to − 0.82) |  < 0.001 | 7163.36 (5927.45–8139.5) | 0.35 (0.29–0.4) | − 1.12 (− 1.32 to − 0.92) |  < 0.001 | 58,860.14 (50,122.62–66,326.97) | 2.87 (2.44–3.23) | 0.54 (0.31 to 0.78) |  < 0.001 | 483,867.67 (412,704.51–544,244.39) | 23.59 (20.11–26.54) | 0.64 (0.35 to 0.92) |  < 0.001 |
Ovarian cancer | 1,294,995.57 (1,125,255.2–1,446,127.87) | 64.04 (55.59–71.56) | − 0.2 (− 0.32 to − 0.07) | 0.002 | 25,257.83 (22,047.49–28,131.91) | 1.24 (1.08–1.38) | − 0.26 (− 0.39 to − 0.12) |  < 0.001 | 85,748.81 (74,200.59–95,797.26) | 4.27 (3.69–4.78) | 0.23 (0.13 to 0.33) |  < 0.001 | 522,318.7 (452,336.73–584,164.21) | 26.14 (22.61–29.26) | 0.42 (0.33 to 0.51) |  < 0.001 |
Benign and in situ cervical and uterine neoplasms | NA | NA | NA | NA | NA | NA | NA | NA | 491,979.2 (315,141.32–729,851.7) | 24.81 (15.89–36.82) | 0.34 (0.11 to 0.57) | 0.004 | 1,373,743.89 (926,463.55–1,919,949.3) | 68.54 (46.19–95.78) | 0.15 (− 0.12 to 0.42) | 0.272 |
Other gynecological diseases | 11,541,889.1 (7,025,556.83–17,560,389.09) | 577.82 (351.42–879.75) | − 0.12 (− 0.15 to − 0.1) |  < 0.001 | 2676.82 (1690.8–3388.68) | 0.14 (0.09–0.17) | 0.28 (0.14 to 0.41) |  < 0.001 | 358,267,612.4 (252,575,236.83–477,616,931.37) | 18,020.33 (12,705.37–24,031.07) | − 0.11 (− 0.13 to − 0.09) |  < 0.001 | 400,683,775.69 (294,902,854.99–524,342,218.88) | 20,089.73 (14,773.4–26,322.7) | − 0.09 (− 0.11 to − 0.07) |  < 0.001 |